News

Telangana Chief Minister A Revanth Reddy expressed profound grief over the demise of renowned actress and Padma Bhushan awardee B Saroja Devi, who passed away in Bengaluru today.
Born in Visakhapatnam in 1956, Dr. Reddy rose from humble beginnings to build AIG into a global centre of excellence. Dr. Reddy’s journey is as inspiring as it is unconventional ...
The term 'trailblazer' is often used casually nowadays, but in the early twentieth century, there was a woman in India who ...
Telangana Chief Minister A Revanth Reddy today said that highly renowned gastroenterologist and the Chairman of AIG (Asian Institute of Gastroenterology) Hospitals in Hyderabad, Dr Nageshwar Reddy is ...
Speaking at the inauguration of the new branch of AIG Hospitals at Banjara Hills, Revanth Reddy praised the contribution of ...
MLC K Kavitha has demanded that the Central government confer the Padma Shri on renowned Karimnagar surgeon Dr Bhoom Reddy, citing his medical contributions and association with former Prime Minister ...
Get Students Protection Forum News on Telangana Today, Students Protection Forum latest news, Students Protection Forum news, | Telangana Today ...
Dr. Reddy's Laboratories Ltd. 500124 shares slid 1.47% to 1,321.20 Indian rupees Thursday, on what proved to be an all-around favorable trading session for the stock market, with the BSE SENSEX ...
Notably, Shobana’s daughter, Upasana Konidela, tied the knot with Telugu superstar Ram Charan in 2012, creating a fascinating connection between the Reddy family and the film royalty of Andhra Pradesh ...
Hyderabad: Showcasing the extraordinary journey from humble beginnings to becoming a trailblazer in India’s infrastructure sector, the biography of Dr A.V.S. Raju, Padma Shri awardee and founder ...
Dr. Reddy’s has benefitted significantly from gRevlimid sales in the US in the last three years. But that opportunity is now closing by FY26-end. The company has made significant investments ...
In recent trading, shares of Dr. Reddy's Laboratories Ltd. (Symbol: RDY) have crossed above the average analyst 12-month target price of $15.40, changing hands for $15.53/share. When a stock ...